Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Asymchem Laboratories (Tianjin) Co., Ltd.
  6. News
  7. Summary
    002821   CNE100002BZ6

ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.

(002821)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

China stocks slip as healthcare firms retreat; Hong Kong up

06/24/2021 | 12:31am EST

* SSEC -0.2%, CSI300 -0.2%, HSI 0.1%

* HK->Shanghai Connect daily quota used 4.4%, Shanghai->HK daily quota used 2.2%

* FTSE China A50 -0.1%

SHANGHAI, May 28 (Reuters) - China shares ticked lower on Thursday, dragged down by losses in the healthcare sector as drugmakers retreated on concerns over a plunge in medicine prices.

** The CSI300 index fell 0.2% to 5,137.37 points at the end of the morning session, while the Shanghai Composite Index lost 0.2% to 3,561.01 points.

** Leading the declines, the CSI300 healthcare index slumped 2.6% by the midday break after price slumps were shown in the results of the fifth national government-backed drug bulk-buy program.

** Hengrui, Guangzhou Kingmed Diagnostics Group Co Ltd, Asymchem Laboratories Tianjin Co Ltd , Bloomage Biotechnology Corp Ltd declined between 4.1% and 6.8%.

** Average price cut was 56% among the 251 products for 61 types of medicines included in the list of preliminary bid winners, state news agency Xinhua said in a report.

** Investors need to pay more attention to drugmakers' overall strength given a normalised bulk-buy mechanism, TF Securities said in a report, adding that bigger-than-expected price declines would be a risk for firms going forward.

** China's monthly producer price index (PPI) is likely to rise 10% in June, piling pressure on downstream consumers, a senior official of China's banking and insurance watchdog told a forum in Beijing on Thursday.

** On Wednesday, two Federal Reserve officials said a period of high inflation in the United States could last longer than anticipated, just a day after Fed Chair Jerome Powell played down rising price pressures.

** The Biden administration ordered a ban on U.S. imports of a key solar panel material from Chinese-based Hoshine Silicon Industry Co over forced labour allegations, said two sources briefed on the matter.

** Hoshine Silicon tumbled 9.9% after the U.S. ban.

** The Hang Seng index added 0.1% to 28,838.96 points, while the Hong Kong China Enterprises Index gained 0.1%, to 10,679.86. (Reporting by Luoyan Liu and Andrew Galbraith; Editing by Aditya Soni)


ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD. -0.81% 345.69 End-of-day quote.-20.53%
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED -3.06% 126.31 End-of-day quote.-18.67%
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. 0.97% 88.2 End-of-day quote.-20.80%
HANG SENG 0.00% 24917.03 Real-time Quote.6.49%
HOSHINE SILICON INDUSTRY CO., LTD. -2.39% 107.42 End-of-day quote.-18.60%
JIANGSU HENGRUI MEDICINE CO., LTD. -1.64% 44.94 End-of-day quote.-11.38%
All news about ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
01/20Asymchem Laboratories Appoints Co-CEOs; Amends Titles of Other Senior Management Execs
MT
01/19Asymchem Laboratories Co., Ltd. Announces Executive Changes
CI
01/19Asymchem Laboratories Co., Ltd. Announces Executive Changes
CI
01/11AUM Biosciences Identifies Asymchem as the CDMO Partner of Choice for their Novel TRK i..
CI
2021Hong Kong Stocks Snap Three-Day Winning Streak; Newcomers Fail to Book Gains in Trading..
MT
2021Asymchem Laboratories Shares Open Flat, Continues Streak of Lackluster Hong Kong Debuta..
MT
2021Asymchem Laboratories Prices Hong Kong IPO at Midpoint of Guidance, Raising $878 Millio..
MT
2021Asymchem Laboratories to Raise $917 Million After Pricing Hong Kong IPO at Midpoint of ..
MT
2021Asymchem Laboratories Co., Ltd. has filed an IPO in the amount of HKD 7.550314 billion.
CI
2021Asymchem Laboratories Plans to Raise $968 Million in Hong Kong IPO
DJ
More news
Financials
Sales 2021 4 339 M 684 M 684 M
Net income 2021 991 M 156 M 156 M
Net cash 2021 9 022 M 1 423 M 1 423 M
P/E ratio 2021 85,1x
Yield 2021 0,22%
Capitalization 89 246 M 14 079 M 14 080 M
EV / Sales 2021 18,5x
EV / Sales 2022 12,0x
Nbr of Employees 5 477
Free-Float 60,5%
Chart ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Duration : Period :
Asymchem Laboratories (Tianjin) Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 345,69 CNY
Average target price 461,13 CNY
Spread / Average Target 33,4%
EPS Revisions
Managers and Directors
Rui Yang Co-Chief Executive Officer & Director
Hao Hong Chairman & Co-Chief Executive Officer
Da Zhang Chief Financial Officer & Director
James Randolph Gage Chief Scientific Officer
Kun Zhang Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.-20.53%14 079
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356